PILA PHARMA AB (5KC) Stock Statistics & Valuation Metrics

PILA PHARMA AB has a market cap or net worth of €5.30M. The enterprise value is €46.23M.

PILA PHARMA AB has 45,682,120 shares outstanding. The number of shares has decreased by -2.65% in one year.

PILA PHARMA AB’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -53.40%.

The current PE Ratio of PILA PHARMA AB is ―. PILA PHARMA AB’s PEG ratio is -0.37.

In the last 12 months, PILA PHARMA AB had revenue of 1.13M and earned -16.86M in profits. Earnings per share was -0.49.

In the last 12 months, operating cash flow was -6.63M and capital expenditures 0.00, giving a free cash flow of -6.63M billion.

PILA PHARMA AB pays an annual dividend of ―, resulting in a dividend yield of ―

PILA PHARMA AB upcoming earnings date is Aug 27, 2026, Before Open (Confirmed).

PILA PHARMA AB as a current ratio of 11.26, with Debt / Equity ratio of 0.00%

In the past 12 months, PILA PHARMA AB has paid 0.00 in taxes.

PILA PHARMA AB EV to EBITDA ratio is -3.48, with an EV/FCF ratio of -6.03.

PILA PHARMA AB has €15.90M in cash and marketable securities with €0.00 in debt, giving a net cash position of €15.90M billion.

Gross margin is -528.70%, with operating margin of -700.44%, and net profit margin of -1496.27%.

The average price target for PILA PHARMA AB is ―, which is 11.43% higher than the current price. The consensus rating is ―